Wuest M et al. conducted an analysis of 56 TNBC and 112 ER+ breast cancer samples, and they revealed elevated levels of LOXL4 and HIF-1α mRNA in the cancer tissues of TNBC patients compared with those of ER+ breast cancer patients 68. This evidence concerns the gene LOXL4 and breast carcinoma.